Concur’s mission is to drive costs out of businesses through innovation. Here’s a new client case study that demonstrates how one company uses Concur to help them drive costs out of their business.
When Takeda UK, a wholly owned subsidiary of Takeda – Japan’s largest pharmaceutical company, was looking to replace its labor-intensive travel and expense claim and invoice process, it saw Concur® Travel & Expense with Concur® Invoice as the perfect solution to “reduce costs, enforce travel policy, improve efficiency and provide total visibility”, according to Bill Walker, Takeda UK’s Finance & HR Director.
Concur Travel & Expense streamlined and automated Takeda UK’s whole process. With it, they were able to imbed audit rules into their process for easier authorization, scan in receipts, link to company credit cards and handle mileage claims efficiently.
As with other pharmaceutical companies, Takeda UK deals with a large amount of paper-based invoices and grant requests. Because of this, the organization decided to implement Concur Invoice as a way to better record, process, trace and certify as compliant the regular and one-off spend and grant requests they receive each month.
Takeda UK found the following benefits from implementing Concur Travel & Expense with Concur Invoice -- the end-to-end, on-demand solution:
- Significant increase in efficiency in the overall travel and expense management process
- No requirement for IT involvement
- Automated approval workflow, integrated with invoices and T&E expenses
- Clear line-of-sight into employee expense claims and travel booking
- Enhanced visibility
- Interface to accounting packages
“Concur Travel & Expense and Concur Invoice was just what Takeda UK needed,” Walker added. “Our employees are pleased with the system and no longer see expense claims and invoices as a chore. We’ve also seen significant advantages accumulate with our outsourced providers.” Takeda is currently looking to implement Concur Travel & Expense and Concur Invoice in all of its European offices.